Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126599932 | 12659993 | 2 | F | 20160814 | 20160817 | 20160819 | EXP | CA-PFIZER INC-2016335872 | PFIZER | 51.00 | YR | M | Y | 0.00000 | 20160819 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126599932 | 12659993 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 20 MG, WEEKLY | 11719 | 20 | MG | /wk | ||||||||
| 126599932 | 12659993 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 6 | SS | REMICADE | INFLIXIMAB | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 7 | SS | RITUXAN | RITUXIMAB | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 8 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MG, 2X/DAY | 0 | 200 | MG | BID | ||||||||
| 126599932 | 12659993 | 9 | SS | GOLD | GOLD | 1 | UNK | 0 | |||||||||||
| 126599932 | 12659993 | 10 | SS | ARAVA | LEFLUNOMIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 126599932 | 12659993 | 11 | C | LYRICA | PREGABALIN | 1 | Oral | UNK | 0 | ||||||||||
| 126599932 | 12659993 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 15 MG, DAILY | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126599932 | 12659993 | 1 | Rheumatoid arthritis |
| 126599932 | 12659993 | 2 | Rheumatoid arthritis |
| 126599932 | 12659993 | 11 | Neuropathy peripheral |
| 126599932 | 12659993 | 12 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126599932 | 12659993 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126599932 | 12659993 | Cytology abnormal | |
| 126599932 | 12659993 | Drug ineffective | |
| 126599932 | 12659993 | Drug intolerance | |
| 126599932 | 12659993 | Prerenal failure | |
| 126599932 | 12659993 | Renal disorder | |
| 126599932 | 12659993 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126599932 | 12659993 | 2 | 1990 | 2008 | 0 | |
| 126599932 | 12659993 | 7 | 2015 | 0 | ||
| 126599932 | 12659993 | 8 | 201001 | 201101 | 0 | |
| 126599932 | 12659993 | 10 | 2007 | 2008 | 0 |